Characterization of Histopathological Features that Differentiate Hepatitis B Virus Infection from Acute Cellular Rejection
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : Differentiation of viral hepatitis from acute cellular rejection (ACR) after liver transplantation can be difficult because of overlapping histological features. Here we investigated clinicopathologic characteristics of 311 liver allograft biopsies and searched for characteristic histopathological features that would facilitate the differential diagnosis between hepatitis B virus (HBV) infection and ACR. Methods : A retrospective clinicopathologic examination of 311 liver allograft biopsies consisting of clinically proven ACR or HBV infection was performed. Immunohistochemical staining for HBcAg and HBsAg was done for 64 allograft biopsies showing HBV infection. Results : Moderate to severe bile duct damage, diffuse centrilobular necrosis and centrilobular inflammation (p<0.000, for each) were more frequently observed in cases of ACR, whereas diffuse acidophilic bodies and spotty necrosis (p<0.000, for each) were more prevalent in cases of HBV infection. Immunopositivity for HBcAg (n=60, 93.8%) was higher than that for HBsAg (n=14, 21.9%). Conclusions : The presence of moderate to severe bile duct damage, diffuse centrilobular necrosis and centrilobular inflammation was a characteristic feature of ACR, whereas diffuse distribution of acidophilic bodies or spotty necrosis was the only characteristic feature of HBV infection. HBcAg was a more sensitive immunohistochemical marker than HBsAg for detecting HBV infection in liver allograft biopsies.
Abstract
Background : Differentiation of viral hepatitis from acute cellular rejection (ACR) after liver transplantation can be difficult because of overlapping histological features. Here we investigated clinicopathologic characteristics of 311 liver allograft biopsies and searched for characteristic histopathological features that would facilitate the differential diagnosis between hepatitis B virus (HBV) infection and ACR. Methods : A retrospective clinicopathologic examination of 311 liver allograft biopsies consisting of clinically proven ACR or HBV infection was performed. Immunohistochemical staining for HBcAg and HBsAg was done for 64 allograft biopsies showing HBV infection. Results : Moderate to severe bile duct damage, diffuse centrilobular necrosis and centrilobular inflammation (p<0.000, for each) were more frequently observed in cases of ACR, whereas diffuse acidophilic bodies and spotty necrosis (p<0.000, for each) were more prevalent in cases of HBV infection. Immunopositivity for HBcAg (n=60, 93.8%) was higher than that for HBsAg (n=14, 21.9%). Conclusions : The presence of moderate to severe bile duct damage, diffuse centrilobular necrosis and centrilobular inflammation was a characteristic feature of ACR, whereas diffuse distribution of acidophilic bodies or spotty necrosis was the only characteristic feature of HBV infection. HBcAg was a more sensitive immunohistochemical marker than HBsAg for detecting HBV infection in liver allograft biopsies.
참고문헌 (21)
- Chen CL, "Living-donor liver transplantation: 12 years of experience in Asia", Transplantation, 75, pp.S6~S11 (2003)
- Jiao ZY, "Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen", Transplant Proc, pp.1533~1536 (2007)
- Jurim O, "Liver transplantation for chronic hepatitis B in Asians", Transplantation, 57, pp.1393~1395 (1994)
- Kim WR, "Outcome of liver transplantation for hepatitis B in the United States", Liver Transpl, 10, pp.968~974 (2004)
- Roche B, "Liver transplantation for hepatitis B virus-related liver disease: indications, prevention of recurrence and results", J Hepatol, 39(1), pp.S181~S189 (2003)
- Samuel D, "Liver transplantation in European patients with the hepatitis B surface antigen", N Engl J Med, 329, pp.1842~1847 (1993)
- Hubscher SG, "Transplantation pathology. in: MacSween’s Pathology of the Liver", pp.815~861 (2007), Churchill-Livingstone
- Florman S, "The incidence and significance of late acute cellular rejection (>1,000 days) after liver transplantation", Clin Transplant, 18, pp.152~155 (2004)
- Demetris AJ, "Banff schema for grading liver allograft rejection: an international consensus document", Hepatology, 25, pp.658~663 (1997)
- Yeh MM, "Endotheliitis in chronic viral hepatitis: a comparison with acute cellular rejection and non-alcoholic steatohepatitis", Am J Surg Pathol, 30, pp.727~733 (2006)
- Demetris AJ, "Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis", Am J Surg Pathol, 28, pp.658~669 (2004)
- Demetris AJ, "Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection", Am J Pathol, 125, pp.161~172 (1986)
- Demetris AJ, "Liver biopsy interpretation for causes of late liver allograft dysfunction", Hepatology, 44, pp.489~501 (2006)
- Demetris AJ, "Real-time monitoring of acute liver-allograft rejection using the Banff schema", Transplantation, 74, pp.1290~1296 (2002)
- Hassoun Z, "Centrilobular necrosis after orthotopic liver transplantation: association with acute cellular rejection and impact on outcome", Liver Transpl, 10, pp.480~487 (2004)
- Demetris AJ, "Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations", Am J Pathol, 137, pp.667~676 (1990)
- Thung SN, "Histologic findings in recurrent HBV", Liver Transpl, 12, pp.S50~S53 (2006)
- Walker N, "Hepatitis B virus infection in liver allografts", Am J Surg Pathol, 17, pp.666~677 (1993)
- Lee HK, "Fibrosing cholestatic hepatitis: A report of three cases", J Korean Med Sci, 15, pp.111~114 (2000)
- 장선희, "간이식 후 재발한 바이러스간염 - 4예 보고 -", The Korean Journal of Pathology, 36(2), pp.122~127 (2002), 대한병리학회
- Lovell MO, "Acute hepatic allograft rejection: a comparison of patients with and without centrilobular alterations during first rejection episode", Liver Transpl, 10, pp.369~373 (2004)